EYE vs PTX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

PTX

PRESCIENT FPO [PTX]

58MEDIUM

Score Breakdown

EYE PTX
Technical
57
83
Catalyst
53
53
Sentiment
50
50
Fundamental
76
53
Momentum
39
75
Risk Gate
45
50

Key Metrics

EYE Metric PTX
$32.8MMarket Cap$78.9M
269KAvg Volume (20d)886K
N/AShort InterestN/A
$0.20552-Week High$0.125
$0.10052-Week Low$0.040
+0.0%Daily Change+5.3%
$0.115Reference Price$0.079
-42.4%ROE-54.3%
-21.3%Profit Margin-207.7%

Active Signals

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

PTX Signals

●MACD momentum is picking up steam
●Trading above both moving averages — the trend is your friend here
●On a tear — up 11.3% over the last 5 days
●Beating the Small Ords index — relative strength of 1.31, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (5 quarters)
●4C filed 2026-04-29
●Revenue declining (-7%)

Ask Scout AI to compare EYE and PTX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs RHT →EYE vs SOM →EYE vs SPL →EZZ vs HMD →EZZ vs MEM →
EYE Full Analysis → PTX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).